Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.

Welsbie DS, Xu J, Chen Y, Borsu L, Scher HI, Rosen N, Sawyers CL.

Cancer Res. 2009 Feb 1;69(3):958-66. doi: 10.1158/0008-5472.CAN-08-2216. Epub 2009 Jan 27.

2.

Androgen action and metabolism in prostate cancer.

Green SM, Mostaghel EA, Nelson PS.

Mol Cell Endocrinol. 2012 Sep 5;360(1-2):3-13. doi: 10.1016/j.mce.2011.09.046. Epub 2012 Mar 20. Review.

3.

[Molecular mechanisms involved in hormone resistance of prostate cancer].

Cabrespine A, Guy L, Chollet P, Debiton E, Bay JO.

Bull Cancer. 2004 Oct;91(10):747-57. Review. French.

4.

Androgen axis in prostate cancer.

Culig Z, Bartsch G.

J Cell Biochem. 2006 Oct 1;99(2):373-81. Review.

PMID:
16598769
5.

Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer.

Scher HI, Buchanan G, Gerald W, Butler LM, Tilley WD.

Endocr Relat Cancer. 2004 Sep;11(3):459-76. Review.

6.

The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.

Chatterjee B.

Mol Cell Biochem. 2003 Nov;253(1-2):89-101. Review.

PMID:
14619959
7.

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.

Vis AN, Schröder FH.

BJU Int. 2009 Aug;104(4):438-48. doi: 10.1111/j.1464-410X.2009.08695.x. Epub 2009 Jun 24. Review.

8.

Androgen receptor (AR) aberrations in castration-resistant prostate cancer.

Waltering KK, Urbanucci A, Visakorpi T.

Mol Cell Endocrinol. 2012 Sep 5;360(1-2):38-43. doi: 10.1016/j.mce.2011.12.019. Epub 2012 Jan 8. Review.

PMID:
22245783
9.

Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target.

Shiota M, Yokomizo A, Naito S.

J Mol Endocrinol. 2011 Jul 12;47(1):R25-41. doi: 10.1530/JME-11-0018. Print 2011 Aug. Review.

PMID:
21504942
10.

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

Agoulnik IU, Weigel NL.

J Cell Biochem. 2006 Oct 1;99(2):362-72. Review.

PMID:
16619264
11.

AR, the cell cycle, and prostate cancer.

Balk SP, Knudsen KE.

Nucl Recept Signal. 2008 Feb 1;6:e001. doi: 10.1621/nrs.06001. Review.

12.

Targeting the androgen receptor in prostate and breast cancer: several new agents in development.

Proverbs-Singh T, Feldman JL, Morris MJ, Autio KA, Traina TA.

Endocr Relat Cancer. 2015 Jun;22(3):R87-R106. doi: 10.1530/ERC-14-0543. Epub 2015 Feb 26. Review.

13.

Targeting the androgen receptor pathway in prostate cancer.

Chen Y, Sawyers CL, Scher HI.

Curr Opin Pharmacol. 2008 Aug;8(4):440-8. doi: 10.1016/j.coph.2008.07.005. Epub 2008 Aug 12. Review.

14.

Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity.

Sadar MD.

Cancer Res. 2011 Feb 15;71(4):1208-13. doi: 10.1158/0008-5472.CAN_10-3398. Epub 2011 Feb 1. Review.

15.

The role of histone deacetylases in prostate cancer.

Abbas A, Gupta S.

Epigenetics. 2008 Nov;3(6):300-9. Epub 2008 Nov 24. Review.

16.

"Getting from here to there"--mechanisms and limitations to the activation of the androgen receptor in castration-resistant prostate cancer.

Sharifi N, McPhaul MJ, Auchus RJ.

J Investig Med. 2010 Dec;58(8):938-44. doi: 10.231/JIM.0b013e3181ff6bb8. Review.

17.

A new trick of an old molecule: androgen receptor splice variants taking the stage?!

Guo Z, Qiu Y.

Int J Biol Sci. 2011;7(6):815-22. Epub 2011 Jul 6. Review.

18.

A sting in the tail: the N-terminal domain of the androgen receptor as a drug target.

Monaghan AE, McEwan IJ.

Asian J Androl. 2016 Sep-Oct;18(5):687-94. doi: 10.4103/1008-682X.181081. Review.

19.

[Role of androgen receptors in hormone-refractory prostate cancer: molecular basics and experimental therapy approaches].

Rinnab L, Hessenauer A, Schütz SV, Schmid E, Küfer R, Finter F, Hautmann RE, Spindler KD, Cronauer MV.

Urologe A. 2008 Mar;47(3):314-25. doi: 10.1007/s00120-008-1637-1. Review. German.

PMID:
18273598
20.

Coupling transcription to RNA processing via the p68 DEAD box RNA helicase androgen receptor co-activator in prostate cancer.

Clark EL, Fuller-Pace FV, Elliott DJ, Robson CN.

Biochem Soc Trans. 2008 Jun;36(Pt 3):546-7. doi: 10.1042/BST0360546. Review.

PMID:
18482004

Supplemental Content

Support Center